A detailed history of Kingsview Wealth Management, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Kingsview Wealth Management, LLC holds 123,629 shares of PFE stock, worth $3.31 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
123,629
Previous 295,451 58.16%
Holding current value
$3.31 Million
Previous $8.27 Million 56.73%
% of portfolio
0.08%
Previous 0.21%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$27.7 - $31.39 $4.76 Million - $5.39 Million
-171,822 Reduced 58.16%
123,629 $3.58 Million
Q2 2024

Aug 14, 2024

BUY
$25.26 - $29.6 $5.15 Million - $6.04 Million
203,992 Added 223.04%
295,451 $8.27 Million
Q1 2024

May 09, 2024

SELL
$25.89 - $29.73 $165,126 - $189,617
-6,378 Reduced 6.52%
91,459 $2.54 Million
Q4 2023

Feb 08, 2024

SELL
$26.13 - $33.94 $317,009 - $411,760
-12,132 Reduced 11.03%
97,837 $2.82 Million
Q3 2023

Nov 07, 2023

BUY
$32.09 - $37.51 $199,022 - $232,637
6,202 Added 5.98%
109,969 $3.65 Million
Q2 2023

Aug 10, 2023

SELL
$36.12 - $41.79 $33,988 - $39,324
-941 Reduced 0.9%
103,767 $3.81 Million
Q1 2023

May 15, 2023

SELL
$39.39 - $51.28 $95,363 - $124,148
-2,421 Reduced 2.26%
104,708 $4.27 Million
Q4 2022

Feb 13, 2023

BUY
$41.75 - $54.5 $411,613 - $537,315
9,859 Added 10.14%
107,129 $5.49 Million
Q3 2022

Nov 14, 2022

BUY
$43.76 - $53.42 $329,337 - $402,038
7,526 Added 8.39%
97,270 $4.26 Million
Q2 2022

Aug 16, 2022

SELL
$46.53 - $55.17 $1.34 Million - $1.58 Million
-28,694 Reduced 24.23%
89,744 $4.71 Million
Q1 2022

Feb 08, 2024

BUY
$45.75 - $56.69 $1.09 Million - $1.35 Million
23,838 Added 24.37%
121,675 $6.3 Million
Q4 2021

Feb 17, 2022

BUY
$41.32 - $61.25 $1.58 Million - $2.35 Million
38,306 Added 47.8%
118,438 $6.99 Million
Q3 2021

Dec 03, 2021

BUY
$39.25 - $50.42 $66,018 - $84,806
1,682 Added 2.14%
80,132 $3.45 Million
Q2 2021

Aug 17, 2021

BUY
$35.91 - $40.68 $87,907 - $99,584
2,448 Added 3.22%
78,450 $3.1 Million
Q1 2021

May 24, 2021

SELL
$33.49 - $37.77 $395,952 - $446,554
-11,823 Reduced 13.46%
76,002 $2.76 Million
Q4 2020

Feb 16, 2021

BUY
$33.47 - $42.56 $401,573 - $510,634
11,998 Added 15.82%
87,825 $3.23 Million
Q3 2020

Nov 19, 2020

BUY
$31.75 - $37.25 $446,532 - $523,884
14,064 Added 22.77%
75,827 $2.78 Million
Q2 2020

Aug 14, 2020

SELL
$30.12 - $36.54 $1.5 Million - $1.82 Million
-49,897 Reduced 44.69%
61,763 $2.02 Million
Q1 2020

May 11, 2020

BUY
$27.03 - $38.62 $425,073 - $607,338
15,726 Added 16.39%
111,660 $3.65 Million
Q4 2019

Jan 31, 2020

BUY
$32.92 - $37.36 $2.89 Million - $3.28 Million
87,832 Added 1084.08%
95,934 $3.76 Million
Q4 2019

Jan 30, 2020

SELL
$32.92 - $37.36 $2.72 Million - $3.09 Million
-82,631 Reduced 91.07%
8,102 $293,000
Q3 2019

Jan 29, 2020

BUY
$32.49 - $42.13 $64,817 - $84,049
1,995 Added 2.25%
90,733 $3.26 Million
Q2 2019

Jan 29, 2020

BUY
$36.98 - $41.52 $72,221 - $81,088
1,953 Added 2.25%
88,738 $3.84 Million
Q1 2019

Jan 29, 2020

BUY
$37.5 - $41.2 $331,387 - $364,084
8,837 Added 11.34%
86,785 $3.69 Million
Q4 2018

Jan 29, 2020

BUY
$38.47 - $43.86 $269,674 - $307,458
7,010 Added 9.88%
77,948 $3.4 Million
Q3 2018

Jan 29, 2020

BUY
$34.47 - $41.81 $196,444 - $238,275
5,699 Added 8.74%
70,938 $3.13 Million
Q2 2018

Jan 29, 2020

BUY
$32.98 - $35.16 $115,397 - $123,024
3,499 Added 5.67%
65,239 $2.37 Million
Q1 2018

Jan 29, 2020

BUY
$31.91 - $37.02 $1.71 Million - $1.99 Million
53,638 Added 662.03%
61,740 $2.19 Million
Q4 2017

Jan 29, 2020

SELL
$33.26 - $35.29 $53,847 - $57,134
-1,619 Reduced 16.65%
8,102 $293,000
Q3 2017

Jan 29, 2020

BUY
$31.0 - $34.15 $109,461 - $120,583
3,531 Added 57.04%
9,721 $347,000
Q2 2017

Jan 29, 2020

SELL
N/A
-1,354 Reduced 17.95%
6,190 $208,000
Q1 2017

Jan 29, 2020

BUY
N/A
7,544
7,544 $258,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Kingsview Wealth Management, LLC Portfolio

Follow Kingsview Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kingsview Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kingsview Wealth Management, LLC with notifications on news.